Q2 EPS Forecast for Unity Biotechnology Lifted by Analyst
Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Equities researchers at HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for shares of Unity Biotechnology in a research report issued to clients and investors on Wednesday, April 23rd. HC Wainwright analyst M. Caufield now forecasts that the company will post earnings per share […]
